Lund Melanoma Study Group
1 – 10 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Transcriptomic signatures of tumors undergoing T cell attack
(
- Contribution to journal › Article
-
Mark
Immediate increase in perceived energy after exercise during the course of chemotherapy treatment for breast cancer
(
- Contribution to journal › Article
-
Mark
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
(
- Contribution to journal › Article
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
(
- Contribution to journal › Article
-
Mark
Incidence and trends of basal cell carcinoma in Sweden : A population-based registry study
(
- Contribution to journal › Article
- 2021
-
Mark
Multiple primary melanoma incidence trends over five decades, a nation-wide population-based study
(
- Contribution to journal › Article
-
Mark
Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families
(
- Contribution to journal › Article
-
Mark
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
(
- Contribution to journal › Article
-
Mark
The proportion cured of patients with resected stage ii–iii cutaneous melanoma in sweden
(
- Contribution to journal › Article